Skip to main content

FDA approves Teva’s generic EpiPen after yearslong delay

Teva's products are the first cleared by the FDA that are direct generic copies of the EpiPen and could be substituted for the brand-name product by a pharmacist.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.